Deceleration and acceleration capacities of heart rate in patients with drug-resistant epilepsy
- 93 Downloads
Epilepsy and seizures can have dramatic effects on cardiac function. The aim of the present study was to investigate deceleration capacity, acceleration capacity and their 24-h fluctuations of heart rate variability in patients with drug-resistant epilepsy.
Deceleration capacity, acceleration capacity of heart rate and their 24-h dynamics derived from the phase rectified signal averaging method as well as traditional measures were analyzed in 39 patients with drug-resistant epilepsy and 33 healthy control subjects using 24-h electrocardiogram recordings. The discriminatory power of heart rate variability measures were validated by assessment of the area under the receiver operating characteristic curve. Net reclassification improvement and integrated discrimination improvement models were also estimated.
Both deceleration capacity and absolute values of acceleration capacity were significantly lower in patients with drug-resistant epilepsy. The abnormal suppression of absolute deceleration capacity and acceleration capacity values were observed throughout the 24-h recording time (peaked at about 3 to 5 A.M.). Deceleration capacity had the greatest discriminatory power to differentiate the patients from the healthy controls. Moreover, in both net reclassification improvement and integrated discrimination improvement models, the combination of acceleration capacity or deceleration capacity with traditional heart rate variability measures has greater discriminatory power than any of the single heart rate variability features.
Drug-resistant epilepsy was associated with a significant inhibition of vagal modulation of heart rate, which was more pronounced during the night than during the day. These findings indicate that phase rectified signal averaging method may serve as a complementary approach for characterizing and understanding the neuro-pathophysiology in epilepsy, and may provide a new clue to sudden unexpected death in epilepsy.
KeywordsDeceleration capacity Acceleration capacity Drug-resistant epilepsy Heart rate variability Autonomic nervous system
The authors gratefully acknowledge Professor Meng Fangang and Zhang Jianguo in Beijing Tian Tan Hospital for their valuable work in diagnosing patients with drug-resistant epilepsy. We also thank Sanbo Brain Hospital Capital Medical University, TsingHua University YuQuan Hospital, Peking University First Hospital FengTai Hospital, Chinese PLA General Hospital, First Affiliated Hospital of PLA General Hospital and Navy General Hospital for their medical technological support.
This work was supported by the National Key Technology R&D Program funded by Ministry of Science and Technology, sponsored by the Chinese Government (2012BAI16B01, 2013BAI03B03, 2015BAI01B08, 2016YFC1305703).
Compliance with ethical standards
Conflict of interest
All authors declare that they have no conflict of interest.
The study protocol was approved by the Institutional Review Committee of Beijing Tiantan Hospital Capital Medical University (No. qx2014-010-02), and all subjects (or parents/guardians of subjects) provided written informed consent.
- 4.Romigi A, Albanese M, Placidi F, Izzi F, Mercuri NB, Marchi A, Liguori C, Campagna N, Duggento A, Canichella A, Ricciardo RG, Guerrisi M, Marciani MG, Toschi N (2016) Heart rate variability in untreated newly diagnosed temporal lobe epilepsy: evidence for ictal sympathetic dysregulation. Epilepsia 57:418–426CrossRefGoogle Scholar
- 9.Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043–1065Google Scholar
- 16.Fujiwara K, Miyajima M, Yamakawa T, Abe E, Suzuki Y, Sawada Y, Kano M, Maehara T, Ohta K, Sasai-Sakuma T, Sasano T, Matsuura M, Matsushima E (2016) Epileptic seizure prediction based on multivariate statistical process control of heart rate variability features. IEEE Trans Biomed Eng 63:1321–1332CrossRefGoogle Scholar
- 19.Nelson W, Tong YL, Lee JK, Halberg F (1979) Methods for cosinor-rhythmometry. Chronobiologia 6:305–323Google Scholar
- 24.Pagani M, Lombardi F, Guzzetti S, Sandrone G, Rimoldi O, Malfatto G, Cerutti S, Malliani A (1984) Power spectral density of heart rate variability as an index of symptho-vagal interactions in normal and hypertensive subjects. J Hypertens Suppl 2:383–385Google Scholar
- 27.Graatsma EM, Mulder EJ, Vasak B, Lobmaier SM, Pildner von Steinburg S, Schneider KT, Schmidt G, Visser GH (2012) Average acceleration and deceleration capacity of fetal heart rate in normal pregnancy and in pregnancies complicated by fetal growth restriction. J Matern Fetal Neonatal Med 25:2517–2522CrossRefGoogle Scholar
- 28.Nasari Junior O, Benchimol-Barbosa PR, Pedrosa RC, Nadal J (2015) Assessment of autonomic function by phase rectification of RR interval histogram analysis in Chagas disease. Arq Bras Cardiol 104:450–455Google Scholar
- 34.Shobha N, Satishchandra P, Sathyaprabha TN, Udupa K (2007) A study of interictal cardiac autonomic functions in patients with refractory complex partial epilepsy secondary to medial lobe pathology: before and after surgery. Neurol Asia 12:69–70Google Scholar